The nation of Zimbabwe has rejected a major American health deal worth 367 million US dollars (£272m) spanning five years over Washington's request for sensitive biological samples.
This move was revealed following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official representative later explained that the United States was demanding access to health data for scientific study and commercial purposes but refused to guarantee the benefits from future treatments.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further negotiations to secure a deal suitable to all parties so the country's vital HIV treatment initiative can be sustained.
Broader Context
This development follows a similar case in neighbouring Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump claimed its spending was "inefficient" and his government was seeking direct bilateral agreements to boost transparency and responsibility.
According to reports, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might result from that provided information," his statement read.
"Put simply, our country would supply the basic resources for medical research with no certainty that the resulting innovations would be accessible to our people should a new health crisis arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending frameworks already established through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage further dialogue with our US partners on how future collaboration might be designed in a way that honours the sovereignty and interests of both nations."
Medical Community Reaction
Medical experts said it recognised the government's concerns, but suggested that negotiations should continue considering a large portion of the country's Aids initiatives relied on external financing.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it added.
The situation underscores the complex debate between receiving crucial international aid and protecting national sovereignty in an increasingly interconnected world.